Andrii Zastrozhnov
Minors between the age of 16 and 18 who wish to receive hormone treatments may do so only in clinical trial settings approved by an institutional review board, the hospital said.

Ryan Anderson, president of the Ethics and Public Policy Center, praised the changes and called for additional protections for children with gender dysphoria.

Read More: National Catholic Register